Home › Trial NCT06099639
Medical Access Program for Patritumab Deruxtecan
- Trial IDNCT06099639
- StatusUnknown
- PhaseN/A
- Study typeExpanded_Access
- SponsorDaiichi Sankyo
- Enrollment—
- Start date—
- ConditionsEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.